阿司匹林对社区老年人握力和步速的影响:ASPREE研究
中位4.7年随访显示,两组握力变化(β: 0.001; 95% CI: -0.004 to 0.005)和步速变化(β: -0.004; 95% CI: -0.010 to 0.001)无显著差异,新发握力减弱和步速缓慢风险亦无差异。
要点
- 低剂量阿司匹林未改善健康老年人握力或步速的纵向变化。
- 阿司匹林未降低新发握力减弱(HR: 1.05; 95% CI: 1.00, 1.10)风险。
- 阿司匹林未降低新发步速缓慢(HR: 1.00; 95% CI: 0.95, 1.05)风险。
核心结论
- 在相对健康的老年人中,低剂量阿司匹林不影响握力和步速的纵向变化,也不降低新发握力减弱和步速缓慢的风险。
主要发现
- 中位4.7年随访期间,握力变化(β: 0.001; 95% CI: -0.004 to 0.005)和步速变化(β: -0.004; 95% CI: -0.010 to 0.001)在阿司匹林组与安慰剂组间无显著差异。
- 研究期间共6203例发生新发握力减弱,6947例发生新发步速缓慢。
- 新发握力减弱风险(HR: 1.05; 95% CI: 1.00, 1.10)和新发步速缓慢风险(HR: 1.00; 95% CI: 0.95, 1.05)在两组间无差异。
临床怎么用
- 对于无明确心血管病、痴呆及日常生活活动受限的社区老年人,不应期望通过低剂量阿司匹林改善握力或步速。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Grip strength and gait speed are key markers of physical functional capacity and general health in older people. This study aimed to examine the effect of low-dose aspirin on handgrip strength and habitual gait speed in relatively healthy older people. METHODS: The ASPREE (ASPirin in Reducing Events in the Elderly) trial randomized 19 114 community-dwelling Australians and US adults aged 70+ years (US minorities ≥65 years) who were free of overt cardiovascular disease, dementia, and limitations in activities of daily living to daily 100 mg aspirin versus placebo. Linear mixed models were used to compare the effects of treatment groups on changes in grip strength and gait speed over time, and Cox proportional hazard models were used to compare time to incident grip weakness and gait slowness between aspirin and placebo groups. RESULTS: Over a median of 4.7 years, the changes in grip strength (β: 0.001; 95% CI: -0.004 to 0.005) and gait speed (β: -0.004; 95% CI: -0.010 to 0.001) did not differ significantly between aspirin and placebo groups. Over the study period, 6203 participants experienced incident grip weakness, and 6947 had incident gait slowness. There was no difference in the risk of incident grip weakness (Hazard Ratio (HR): 1.05; 95% CI: 1.00, 1.10) and gait slowness (HR: 1.00; 95% CI: 0.95, 1.05) between individuals randomized to aspirin versus placebo. CONCLUSIONS: Low-dose aspirin use in relatively healthy older people did not affect gait speed or grip strength over time or reduce the risk of weakness and slowness.
引用
- Phyo AZZ, Espinoza SE, Orchard SG, et al. Effect of aspirin on grip strength and gait speed in community-dwelling older adults in the ASPirin in Reducing Events in the Elderly (ASPREE) Study. J Gerontol A Biol Sci Med Sci. 2025. PMID: 40929147. doi:10.1093/gerona/glaf198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。